Abstract
Two ways of synthesis of theragnostic compounds for Gd-guided boron neutron capture therapy of cancer are proposed. The first way is based on modification of DO3A ligand, which a capable to form stable complexes with gadolinium, with attachment of boron-containing moieties and additional functional groups which can be used for conjugation with various biomacromolecules. The second way is based on the introduction of additional chelating groups into a boron-containing moiety—carborane-based ligand. It is expected that this will significantly improve the stability of the gadolinium bis(dicarbollide) complexes.
GRAPHICAL ABSTRACT
![](/cms/asset/afa7255d-090c-4e61-a46a-1fddd71cc6c8/gpss_a_1804151_uf0001_c.jpg)